![]() |
Acta Pharmacologica Sinica (2009) 30: 1283–1288; doi: 10.1038/aps.2009.128
|
| Original Article | [ Full text ] |
| N-acetylcysteine infusion reduces the resistance index of renal artery in the early stage of systemic sclerosis |
Edoardo ROSATO1,
Rosario CIANCI2, Biagio BARBANO2, Ginevra MENGHI1,
Antonietta GIGANTE2, Carmelina ROSSI1, Enrico M ZARDI3,
Antonio AMOROSO4, Simonetta PISARRI1, Felice SALSANO1, *
|
1Sapienza University of Rome
Department of Clinical Medicine, Clinical Immunology Unit-Scleroderma Center, Italy; 2Sapienza University of Rome
Department of Clinical Medicine, Nefrology Unit, Italy; 3Department of Clinical
Medicine, “Campus Bio-Medico” University, Rome, Italy; 4Sapienza University of Rome Department of
Clinical Medicine, Italy
|
Methods: In an open-label study 40 patients
with systemic sclerosis (SSc) were treated with N-acetylcysteine (NAC) iv infusion over 5 consecutive hours, at a dose of
Results: NAC infusion significantly reduced RI in a group of sclerodermic patients with early/active capillaroscopic pattern, modified Rodnan Total Skin Score (mRTSS) <14 and mild-moderate score to the vascular domain of Medsger Scleroderma Disease Severity Scale (DSS). RI increased after NAC infusion in patients with late capillaroscopic pattern, mTRSS>14 and severe-end stage score to the vascular domain of DSS. In patients with reduction of RI after NAC infusion, diffusion capacity for carbon monoxide mean value was significantly higher than in those patients with an increase of RI. No significant differences in renal blood flow were found between patients with different subsets of SSc.
Conclusion: In patients
with low disease severity NAC ameliorates vascular renal function.
|
Keywords:
|
|
[ Full text ] |
Copyright©APS 2009 Add: 294 Tai-Yuan Road, Shanghai 200031, China Phn: 86-21-5492-2821 Fax: 86-21-5492-2823 E-mail: aps@mail.shcnc.ac.cn |